• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Case Rep . Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report

tetano

tetano

Editor, Senior Moderator
Clin Case Rep


. 2024 May 28;12(6):e8791.
doi: 10.1002/ccr3.8791. eCollection 2024 Jun. Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report

Harman Chopra[SUP] 1 [/SUP], Tim Furnish[SUP] 2 [/SUP], Monica Verduzco-Gutierrez[SUP] 3 [/SUP], David S Jevotovsky[SUP] 4 [/SUP], Joel Castellanos[SUP] 2 [/SUP]



Affiliations
Abstract

Key clinical message: Long-COVID syndrome lacks effective holistic treatment options. We present a case of a 41-year-old fully vaccinated female with Long-COVID syndrome who obtained significant symptomatic relief after self-medicating with psilocybin and MDMA.
Abstract: Long-COVID, a syndrome persisting after the acute phase of coronavirus disease 2019 (COVID-19), lacks effective holistic treatment options. We present a case of a 41-year-old fully vaccinated female with Long-COVID syndrome who obtained significant symptomatic relief by self-prescribing psilocybin and MDMA. Future research is needed to assess safety and efficacy.

Keywords: COVID‐19; MDMA; case report; long‐COVID; neurotropics; psilocybin.

​
 
You must log in or register to reply here.
Back
Top Bottom